Openbookopenbook
Equity
Empro Group Inc. Ordinary shares(EMPG)
USD --+0.00%
Reward35Moderate
Risk42Moderate
📊75%Data
Revenue growing 142% YoY
EMPG
+0.0 · +0.00%
USD · NASDAQ
Empro Group Inc. Ordinary shares | Healthcare
Structurally Challenged
Market Cap:143.05M
ℹ️
Reward Rating
35
Moderate
Bottom 5% (model universe)
75% data coverage
ℹ️
Risk Rating
42
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on EMPG to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Empro Group Inc. Ordinary shares?

, through its subsidiary, sells healthcare and beauty products in Malaysia and internationally.

EMPG · Verdict

Limited reward · moderate risk

EMPG stands out on volatility and profitability, but watch the growth signal.

Based on 88% data coverage

EMPG · Verdict

What’s working & what to watch

Strengths 2

  • Volatility95/100

    Top decile vs peers

  • Profitability69/100

    14% net margin · 66% ROE

Watchouts 3

  • Growth13/100

    Rev -2.0% CAGR · earnings -2.5%

  • Valuation23/100

    Weak vs peers

  • Cash flow41/100

    -0% free-cash-flow margin

Model-based scoring. For information only — not financial advice.

What is Empro Group Inc. Ordinary shares?

, through its subsidiary, sells healthcare and beauty products in Malaysia and internationally. The company offers eyebrow pencils, skincare and antibacterial moisturizing mist products, surgical face masks, nitrile gloves, test kits, lips natural recovery cream, and black diamond eyeliners under the Empro, Premio, SpaceLift, and Mios brands. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 143.05M, and a P/E ratio of 192.9x.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Adequate profitability with some margin variability in recent periods.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Premium valuation reflects strong growth expectations already priced in.

OpenBook Logo Analysis

Reward: Moderate (35)

The scoring profile indicates weak reward characteristics across most factors, including profitability and momentum. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap143.05M
P/E Ratio192.8889
Dividend YieldN/A
52 Week High18.14
52 Week Low2.55
Last AnnualDecember
IPO Date7/2/2025
IncorporatedUSA
Shares Outstanding8M
No. of Employees33
IndustryMedical Distribution
ExchangeNASDAQ
BetaN/A
CurrencyUSD
Websitewww.empro.my
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.